BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29713518)

  • 1. The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females.
    Kovalenko TF; Morozova KV; Ozolinya LA; Lapina IA; Patrushev LI
    Acta Naturae; 2018; 10(1):43-50. PubMed ID: 29713518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
    Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
    Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the PTENP1 pseudogene as potential epigenetic marker of age-related changes in human endometrium.
    Kovalenko TF; Morozova KV; Pavlyukov MS; Anufrieva KS; Bobrov MY; Gamisoniya AM; Ozolinya LA; Dobrokhotova YE; Shakhparonov MI; Patrushev LI
    PLoS One; 2021; 16(1):e0243093. PubMed ID: 33481830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner.
    Kovalenko TF; Yadav B; Anufrieva KS; Larionova TD; Aksinina TE; Latyshev YA; Bastola S; Shakhparonov MI; Pandey AK; Pavlyukov MS
    Biochimie; 2024 Apr; 219():74-83. PubMed ID: 37619809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of
    Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
    J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?
    Ioffe YJ; Chiappinelli KB; Mutch DG; Zighelboim I; Goodfellow PJ
    Gynecol Oncol; 2012 Feb; 124(2):340-6. PubMed ID: 22005521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pseudogene PTENP1 regulates smooth muscle cells as a competing endogenous RNA.
    Lai Y; Li J; Zhong L; He X; Si X; Sun Y; Chen Y; Zhong J; Hu Y; Li B; Liao W; Liu C; Liao Y; Xiu J; Bin J
    Clin Sci (Lond); 2019 Jul; 133(13):1439-1455. PubMed ID: 31235554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
    Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
    Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
    Kerwin J; Khan I;
    Elife; 2020 Apr; 9():. PubMed ID: 32314732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them].
    Wang CC; Huai L; Zhang CP; Jia YJ; Li QH; Chen YR; Tian Z; Tang KJ; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):896-901. PubMed ID: 23363743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.
    Zhang R; Guo Y; Ma Z; Ma G; Xue Q; Li F; Liu L
    Oncotarget; 2017 Apr; 8(16):26079-26089. PubMed ID: 28212532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PTEN and PTEN pseudogene in endometrial carcinoma.
    Yokoyama Y; Wan X; Shinohara A; Takahashi S; Takahashi Y; Niwa K; Tamaya T
    Int J Mol Med; 2000 Jul; 6(1):47-50. PubMed ID: 10851265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines.
    Hesson LB; Packham D; Pontzer E; Funchain P; Eng C; Ward RL
    Biol Proced Online; 2012 Apr; 14(1):5. PubMed ID: 22490388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma.
    Qian YY; Li K; Liu QY; Liu ZS
    Oncotarget; 2017 Dec; 8(64):107859-107869. PubMed ID: 29296207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.
    Yu G; Yao W; Gumireddy K; Li A; Wang J; Xiao W; Chen K; Xiao H; Li H; Tang K; Ye Z; Huang Q; Xu H
    Mol Cancer Ther; 2014 Dec; 13(12):3086-97. PubMed ID: 25249556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Activity of the Pseudogene
    Yndestad S; Austreid E; Skaftnesmo KO; Lønning PE; Eikesdal HP
    Mol Cancer Res; 2018 Jan; 16(1):78-89. PubMed ID: 29021233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of selected tumor suppressor genes in endometrial hyperplasia.
    Dvorak O; Ndukwe M; Slavickova M; Laco J; Spacek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):68-73. PubMed ID: 36628559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN.
    Guo X; Deng L; Deng K; Wang H; Shan T; Zhou H; Liang Z; Xia J; Li C
    Anticancer Agents Med Chem; 2016; 16(4):456-64. PubMed ID: 25968876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.